Induran Ventures Inc.

Induran Ventures Inc.Induran Ventures Inc.Induran Ventures Inc.

Induran Ventures Inc.

Induran Ventures Inc.Induran Ventures Inc.Induran Ventures Inc.
  • Home
  • SignPost
  • GraySpace
  • More
    • Home
    • SignPost
    • GraySpace
  • Home
  • SignPost
  • GraySpace

Impact Investing with Induran

Impact Investing with InduranImpact Investing with InduranImpact Investing with Induran

Induran is a Venture Philanthropy General Partner

Impact Investing with Induran

Impact Investing with InduranImpact Investing with InduranImpact Investing with Induran

Induran is a Venture Philanthropy General Partner

Where Venture Meets Philanthropy

Induran Venture Accomplishments

Induran accelerates ground breaking technologies that solve problems confronting humans. Induran has experience starting, growing, and running companies across the spectrum of biotechnology, including the world`s first continuous process bio fuel refinery, eco-friendly agriculture, anti viral therapeutics, drug delivery technology, novel therapeutics, and molecular diagnostics. 



1 min clip from the Deal Flow Show

A short clip from the interview with CEO Peter Blaney on his investing philosophy. The full interview with The Deal Flow Show podcast covers how the pipeline stays full, what determines a good market and the effects of COVID-19 on the Biotech market. 

image115

Venture Philanthropy is Social Impact Investing

After productive careers in pharmaceuticals and venture capital the Induran Partners are focused on social impact investing, through venture philanthropy. 

We have run philanthropic campaigns. And we have decades of experience investing in early stage companies developing life saving products.

We have worked with Family Offices, Qualified Investors, Angel Networks, and Multinational Corporations.

image116

Invest in GraySpace for Social Impact

GraySpace Therapeutics Inc. is in the first wave of a new class of pharmaceutical companies that treat specific ailments by slowing fundamental processes associated with aging.

Our initial target is people suffering from neurodegenerative diseases like Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Ultimately our market will include approximately 2 billion adults over 40 years of age facing cognitive decline and neurodegenerative diseases. 

Current Projects

image117

SignPost Cancer Dx Inc.

Induran Ventures founded SignPost Cancer Dx Inc. to create BreastDefense and help advance the worlds shift to precision medicine. 

SignPost is at the very forefront- globally- in the development of molecular diagnostics. If you would like to know more about SignPost visit: www.signpostcancerdx.com

image118

GraySpace Therapeutics Inc.

 

At GraySpace Therapeutics we believe a successful key will be found in plasmalogens.  

Few Pharma companies today have any experience or expertise with plasmalogens.

GraySpace is a world leader in plasmalogen research. Our scientists have been researching plasmalogens for several decades. GraySpace has a strong patent estate surrounding that research. 

Past Projects

image119

Performance Plants

  

A global leader in agricultural and biofuel biotechnology. A plant-trait company with field-tested proven technologies to help farmers, industry and biofuel users meet the challenges of feeding and fueling the world of tomorrow...today.

image120

Defryus Inc.

Defyrus, developed an anti viral therapy ZMapp to treat Ebola.  ZMapp was the first antibody therapy proven effective in treating humans, post exposure, for this highly infectious disease. 

image121

Biox

 The world's first continuous process bio diesel refinery. Biox began as a test plant and now has two manufacturing locations in Canada and a joint venture with the US company World Energy of Houston.

Bio Diesel is a clean high performing alternative to petroleum diesel and is a low cost solution to help combat climate change.

Our Team

image122

Peter Blaney

Barry Markowsky

Peter Blaney

For 30 years Peter has been active in biotechnology start ups that have led to products in bio fuels, agricultural biotech, anti viral therapeutics, drug delivery and molecular diagnostics.

image123

Paul Lucas

Barry Markowsky

Peter Blaney

Paul is Past President and CEO of GlaxoSmithKline Canada. Paul has enormous experience in bringing new technology to the marketplace.

image124

Barry Markowsky

Barry Markowsky

Barry Markowsky

Barry is Past Vice President Development and Director at GlaxoSmithKline Canada. Barry has the unique combination of a science background and experience in negotiating and closing development deals.

Subscribe

Sign up to hear from us.

Contact Us

Send Message

Induran Ventures Inc.

P.O Box 26, Kingston, Ontario, Canada K7L 4V6



Copyright © 2018 Induran Ventures Inc. - All Rights Reserved.